Test For Mycoplasma and Ureaplasma

Last updated:

By Steve Page

A joint test for Mycoplasma and ureaplasma is a rapid blood culture that identifies both organisms. Blood should be collected in an acid citrate dextrose tube. Other specimens, such as swabs, should be inoculated into a transport medium or culture medium, such as PBS. Dacron or polyester swabs are recommended; cotton swabs may inhibit the test.

Testing for both Ureaplasma and Mycoplasma

The current state of the art for PCR assays for Mycoplasmal and ureaplasma infections is limited by several factors.

Most NAATs have not been evaluated or validated against other diagnostic methods and, thus, lack FDA approval. However, a few comparative clinical studies and inter aboratory proficiency testing studies have shown some differences in the sensitivity and specificity of NAATs.

Samples for PCR assays for Mycoplasmal and ureaplasma should be collected using sterile Dacron or polyester swabs. Cotton swabs may inhibit the PCR reactions.

The specimens should be inoculated into culture media or PBS. The collection procedure should include a suitable culture medium and transport media. PCR assays should be compared to the results of other diagnostic methods and should exceed the detection capacity of culture-based methods.

PCR assays for Mycoplasm and ureaplasma are the preferred diagnostic methods for M. pneumonia and ureaplasma. These assays are highly sensitive and can be used to detect fastidious species such as M. genitalium and ureaplasma in cultured specimens.

This type of assay also has the added advantage of reducing the reliance on a complex and cumbersome culture process.

The latest PCR assays for Mycoplasmacea and Ureaplasma have the added benefit of being sensitive and specific. Genomic sequence data for all 14 Ureaplasma serovars is available, allowing the use of multiplex real-time PCR assays for species identification. It is recommended that the assays be tested against a wide range of microorganisms to ensure accuracy.

PCR assays for Mycoplasmal and Ureaplasma are widely used in clinical laboratories for the rapid detection of these bacteria. They can detect the presence of mollicutes in a variety of clinical samples.

In addition, these assays can be used to confirm or rule out the presence of microbial infection. Therefore, PCR assays for Mycoplasma and Ureaplasma are invaluable tool for clinical pathology.

The sensitivity of PCR assays for Mycoplasmosis is higher than that of culture. A sensitivity of 96.9% and 79.0% is achieved with a single-PCR assay for Mycoplasma. The sensitivity and specificity of PCR assays for Mycoplasma and Ureaplasma have been widely studied. The use of these assays has revolutionized medical diagnostics.

Cultures for Mycoplasma and Urea-plasma species are considered the reference standard for Mycoplasma detection. However, their use is limited by their high-cost and specialized media.

The confirmation of culture results can take two to five days. Molecular characteristics such as growth rate and hydrolysis of arginine can be used to differentiate different species.

However, the PCR method has been given greater attention due to its usefulness for the detection of perinatal infections.

A PCR assay can confirm the species identity. The phenotypic test cannot distinguish Mycoplasma species that grow on agar. For this reason, it is recommended that you use a PCR assay to identify a specific Mycoplasma species. It is also much more sensitive than culture when it comes to M. hominis. It is also faster and less laborious.

Mycoplasma and Ureaplasma cultures

The medium used in mycoplasma and ureaplasma cultures must be serum enriched. Most mycoplasmas require a 20% v/v serum and most are susceptible to horse serum, although swine serum is often sufficient.

A higher concentration of human serum may also be useful because it contains antibodies and antibiotics. Adding DNA to the medium may also stimulate growth, and Lemcke quotes a concentration of 20 mg/ml of sodium deoxyribonucleate.

Several iron transporters have been implicated in the virulence of Ureaplasma spp. The MBA protein is a major antigen recognized during infection. If growth is absent on the culture medium without serum, it is more likely that mycoplasma is a cause. Mycoplasmas urealyticum can be positively identified by morphology alone, or by using the appropriate culture medium.

Several commercial growth media are available for mycoplasma culture. Specific agar media for each species is available. Some of them contain a pH-dependent inhibitor.

Culture media for Mycoplasma and ureaplasma differ from one another. Some can be differentiated using mass spectrometry. A culture of Ureaplasma urealyticum will grow on Ureaplasma parvum.

Biofilms of Mycoplasma and ureaplasma have been visualized using SEM. Torres-Morquecho et al. used SEM to visualize the ureaplasmas attached to A549 lung epithelial cells.

Because Ureaplasma produces ammonia and CO2, the presence of biofilms in the culture medium can result in toxic concentrations of these by-products. Fortunately, chelation and flow can be used to remove these toxic by-products.

In culture media for Mycoplasma and ureaplasma, dilutions of Ureaplasma are made using viable and active U. parvum. These dilutions are then grown overnight and the lowest dilution with a change in colour is used for inoculation in the flow cell. To check whether the dilutions are viable, dilutions of the cultures should be diluted by 10 times.

Culture media for Mycoplasma and ureaplasma are available for laboratory use. The genital mucosa of the urethra is a common source for Mycoplasma and ureaplasma, which is associated with neoplastic urethritis. Both the male and female genital tracts can be infected.

The agar-based culture media contain a bi-phasic solution of solid Mycoplasma Agar Base and reconstituted Mycoplasma Supplement-P SR0060.

The bi-phasic medium should be inoculated with a fleck of sputum and incubated at 35degC for up to three months. The bi-phasic culture medium must be checked for gross turbidity due to growth during incubation.

The HPA5 strain of U. parvum HPA5 is lacking the biofilm-forming capacity of other strains. This may be due to overincubation and/or to the loss of viability between transfer to fresh culture media.

The viability window is minimal. The bacterial viability peaks before the cell fully changes colour to red. If the media is changed more than six hours after this, there will be a significant loss of viable cells. This effect is likely to be greater for strains with shorter generation times.